Ginsenoside Re

人参皂苷Re

Also known as: Ginsenoside B2, Panaxoside Re, Chikusetsusaponin IVc, Ginsenoside Re (3β,6α,12β)-20-(β-D-glucopyranosyloxy)-3,12-dihydroxydammar-24-en-6-yl 2-O-(6-deoxy-α-L-mannopyranosyl)-β-D-glucopyranoside

Ginsenoside Re (CAS 52286-59-6) is a compound in the Organic Compounds category listed in the Jingsj chemical database. It has the molecular formula C48H82O18 and a molecular weight of 947.154 g/mol. It is also known as Ginsenoside B2, Panaxoside Re and Chikusetsusaponin IVc. Key properties include a melting point of 202 °C(dec.), a boiling point of 1011.8±65.0 °C at 760 mmHg, a density of 1.4±0.1 g/cm3 and a flash point of 565.7±34.3 °C. No supplier offers are currently listed; request a quote. Record last updated Aug 21, 2026.

CAS No.: 52286-59-6
Jingsj CID: J-1970964-6
Molecular Formula: C₄₈H₈₂O₁₈
Chinese Name: 人参皂苷Re
Molecular Weight: 947.154 g/mol
Category: Organic Compounds
Last updated: 8/21/2026

No offers for this compound yet.

Request a quote

Physicochemical Properties

Melting Point	202 °C(dec.)
Boiling Point	1011.8±65.0 °C at 760 mmHg
Density	1.4±0.1 g/cm3
Flash Point	565.7±34.3 °C
Exact Mass	946.550110
PSA	298.14000
LogP	4.75
Vapor Pressure	0.0±0.6 mmHg at 25°C
Refractive Index	1.611

Activity & Biological Data

Target	Aβ1-40 Aβ1-42 NF-κB JNK
Additional Information	[1]. Cao G, et al. Ginsenoside Re reduces Aβ production by activating PPARγ to inhibit BACE1 in N2a/APP695 cells. Eur J Pharmacol. 2016 Dec 15;793:101-108. [2]. Zhang Z, et al. Ginsenoside Re reduces insulin resistance through inhibition of c-Jun NH2-terminal kinase and nuclear factor-kappaB. Mol Endocrinol. 2008 Jan;22(1):186-95. [3]. Su F, et al. Protective effect of ginsenosides Rg1 and Re on lipopolysaccharide-induced sepsis by competitive binding to Toll-like receptor 4. Antimicrob Agents Chemother. 2015 Sep;59(9):5654-63.

Target

Aβ1-40 Aβ1-42 NF-κB JNK

Additional Information

[1]. Cao G, et al. Ginsenoside Re reduces Aβ production by activating PPARγ to inhibit BACE1 in N2a/APP695 cells. Eur J Pharmacol. 2016 Dec 15;793:101-108. [2]. Zhang Z, et al. Ginsenoside Re reduces insulin resistance through inhibition of c-Jun NH2-terminal kinase and nuclear factor-kappaB. Mol Endocrinol. 2008 Jan;22(1):186-95. [3]. Su F, et al. Protective effect of ginsenosides Rg1 and Re on lipopolysaccharide-induced sepsis by competitive binding to Toll-like receptor 4. Antimicrob Agents Chemother. 2015 Sep;59(9):5654-63.

Frequently Asked Questions

What is the CAS number of Ginsenoside Re?

The CAS number of Ginsenoside Re is 52286-59-6.

What are the molecular formula and molecular weight of Ginsenoside Re?

Ginsenoside Re has molecular formula C48H82O18 and molecular weight 947.154 g/mol.

What are the upstream and downstream products of Ginsenoside Re?

For Ginsenoside Re, Downstream Products: Ginsenoside F1, β-D-Glucose, L-Rhamnose monohydrate.

Data compiled from public chemical databases and supplier catalogs; supplier offers are provided by suppliers.

Last updated: 8/21/2026

How to cite: Jingsj. "Ginsenoside Re (CAS 52286-59-6)". Jingsj Chemical Database. https://www.jingsj.com/compound/J-1970964-6 (accessed 2026-10-28).

Data for reference only; verify specifications, grades and regulatory status with suppliers before purchase.